¥4.25 billion in net sales and profit targets for the fiscal year ending March 2020
First written in FY2019. 2 of 7 entries say "Advanced", first in FY2020-Q2. Latest entry: FY2021-Q3.
The whole theme swung hardest in 2021: 1 of 7 companies on the "Worse" side.
1 other company's latest entry also says "Restated".
- FY2021-Q3RestatedAnnual report
「Although the impact of the COVID-19 pandemic and the related state of emergency remains uncertain, we expect revenue to recover to some extent for the full fiscal year as we gradually resume sales activities.」
Without restating the previous specific revenue and profit targets, the company acknowledged the uncertainty related to the pandemic and continued to indicate expectations for full-year revenue recovery through the resumption of sales activities. - FY2021-Q2SoftenedAnnual report
「Although the impact of the COVID-19 pandemic remains uncertain, we expect revenue to recover in the second half as we gradually resume sales activities.」
Without restating the previous specific full-year revenue and profit targets, the company acknowledged the uncertainty related to the pandemic and softened its statement to an expectation of revenue recovery in the second half. - FY2021-Q1SoftenedAnnual report
「Although the impact of the COVID-19 pandemic remains uncertain, we expect revenue to increase for the full fiscal year as we gradually resume sales activities.」
Against the specific revenue and profit targets for the fiscal year ending March 2020 presented previously, the company did not restate numerical targets this quarter, instead indicating expectations for full-year revenue growth while acknowledging uncertainty related to the pandemic. - FY2020-Q3AdvancedAnnual report
「Sales at retail price for the cumulative third quarter were ¥6,294.841 million, compared with ¥5,425.850 million in the same period of the previous year. Our highest priority is to achieve our sales-at-retail-price target together with our sales organization.」
Sales at retail price increased from ¥5,425.850 million in the same period of the previous year to ¥6,294.841 million, indicating progress toward the sales target shared with the sales organization. - FY2020-Q2AdvancedAnnual report
「Sales at retail price for the cumulative second quarter were ¥5,278.928 million, compared with ¥4,370.255 million in the same period of the previous year. Our highest priority is to achieve our sales-at-retail-price target together with our sales organization.」
Sales at retail price increased from ¥4,370.255 million in the same period of the previous year to ¥5,278.928 million, and the company disclosed progress toward the sales target shared with its sales organization. - FY2020-Q1Disclosure of first-quarter progress in sales at retail priceAnnual report
「Sales at retail price for the cumulative first quarter were ¥815.720 million, compared with ¥1,001.427 million in the same period of the previous year. Our highest priority is to achieve our sales-at-retail-price target together with our sales organization.」
The company shares its sales-at-retail-price target with its sales organization as its most important performance indicator and disclosed first-quarter sales at retail price of ¥815.720 million compared with the same period of the previous year. - FY2019First statedAnnual report
「For the fiscal year ending March 2020, we aim to exceed revenue of ¥4,250 million, operating income of ¥200 million, ordinary income of ¥170 million, and net income of ¥150 million, while working to expand sales of our core products, Red Power Serum and White Power Serum, and exercising strict control over expenses.」
For the fiscal year ending March 2020, the company newly presented specific targets for revenue, operating income, ordinary income, and net income, along with sales expansion of its core serums and expense management as the means of achieving them.